UNSPSC 51281621: Propikacin

This classification denotes an aminoglycoside antibiotic with the molecular formula C21H43N5O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9X6F5H479X, chemically known as uk 31,214 but generally known as propikacin, which bears US NIH Compound Identifier 68557. European Medicines Agency schedules Propikacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10107MIG. The term PROPIKACIN is an International Non-Proprietary Name.

UNSPSC 51281621 Propikacin, a Commodity code, shows limited recent state and local procurement activity and the available opportunities do not align with the code's nominal scope. The two most recent records tagged to this code involve pharmaceutical procurement, but neither involves propikacin specifically. The Illinois Department of Public Health awarded a piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, and Seminole County, Florida issued an IFB for Naloxone and Safe Drug Deactivation Systems. Neither opportunity represents propikacin procurement, suggesting either that propikacin is rarely or not currently bought by state and local agencies, or that tagging accuracy under this code is inconsistent.

State and local procurement activity under UNSPSC 51281621 does not support a meaningful business development strategy at this time. The code shows no open solicitations for propikacin itself, and the recent contract awards and active bids in the taxonomy record involve other pharmaceutical products altogether. If pursuing opportunities in the pharmaceutical supply space with state and local agencies, vendors should monitor codes for specific drug formulations and therapeutic classes that match their product lines, or work directly with pharmacy consortium contracts such as MMCAP Infuse that aggregate purchasing across multiple jurisdictions.